Breast Cancer Coverage From Every Angle
Advertisement
Advertisement

G. Thomas Budd, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

Posted: Monday, November 27, 2017

In your community, practice, or institution, does the surgeon identify appropriate candidates for a neoadjuvant regimen, which could include pertuzumab, and refer them to the breast oncologist?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.